CTRI/2024/07/071533
Not yet recruiting
未知
Screening of ocular parameters and visual related quality of life among individuals with end stage kidney disease on maintenance hemodialysis - Nil
Bhimagani Latha sri0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Bhimagani Latha sri
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Age more than 18 years old
- •2\. Both males and females
- •3\. Individuals with end\-stage kidney disease on maintenance hemodialysis
Exclusion Criteria
- •1\.Any connective tissue diseases or genetic conditions
- •2\. Patients using dry eye or anti\-glaucoma medications
- •3\. H/o wearing contact lenses
- •4\. Patients with a history of ocular injury or post\-operative complications
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Evaluation of ocular pathological condition using polarization-sensitive optical coherence tomographyGlaucoma, Glaucoma after trabeculectomy, Keratoconus, Corneal dystrophy, Pterygium, Inflammatory anterior eye diseases, CataractJPRN-UMIN000014774Department of Ophthalmology, Tohoku University Graduate School of Medicine180
Not yet recruiting
Not Applicable
Visual function & Ocular Parameter evaluation in children with Retinopathy of prematurity treated with laserHealth Condition 1: H351- Retinopathy of prematurityCTRI/2020/10/028267Sankara Eye Hospital Bangalore
Recruiting
Not Applicable
Ocular morphometry and visual function following various vitreoretinal surgeryJPRN-UMIN000040613Tsukuba University100
Recruiting
Not Applicable
Investigation of the relationship between ocular structures and development of visual function in children.Pediatric patientsJPRN-UMIN000051767Kimura eye and internal medicine hospital886
Recruiting
Not Applicable
ongitudinal analyses of ocular findings and background factorsOcular diseases and agingJPRN-UMIN000052310Department of Clinical Regenerative Medicine Eye Center, Fujita Medical Innovation Center Tokyo Fujita Health University School of Medicine3,000